What is MOVE's earnings growth forecast for 2026-2026?
(NASDAQ: MOVE) Corvex's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Corvex's earnings in 2026 is -$18,245,000.
In 2026, MOVE is forecast to generate -$29,299,685 in earnings, with the lowest earnings forecast at -$28,150,678 and the highest earnings forecast at -$30,161,441.
What is MOVE's revenue growth forecast for 2026-2026?
(NASDAQ: MOVE) Corvex's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Corvex's revenue in 2026 is $737,000.
In 2026, MOVE is forecast to generate $61,630,372 in revenue, with the lowest revenue forecast at $59,213,495 and the highest revenue forecast at $63,443,030.
What is MOVE's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: MOVE) forecast ROA is -4.85%, which is lower than the forecast US Medical Devices industry average of 9.25%.
What is MOVE's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: MOVE) Corvex's current Earnings Per Share (EPS) is -$17.72. In 2026, MOVE's EPS is forecast to hit -$14.79 (min: -$14.21, max: -$15.23).
What is MOVE's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: MOVE) forecast ROE is -5.09%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.